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Abstract 
The Effects of Biomimetic Proteoglycans On Interstitial Flow-Induced Cancer Invasion 
Priyanka Pratod Kasbekar 
Adrian C. Shieh, Ph.D. 
 
 
 
 
Local microenvironments play a crucial role in cancer biology and the regulation of 
cellular behavior.  A challenge that remains to be studied is the role of the extracellular 
matrix in the transition from normal physiology to a cancerous niche. The matrix of the 
basement membrane and interstitium is made up of fibrous proteins, glycoproteins, 
proteoglycans, and polysaccharides. Proteoglycans are one of the three most abundantly 
found molecules in the extracellular matrix. These proteoglycans interact with soluble 
factors such as chemokines, cytokines, growth factors, and other matrix macromolecules, 
thereby playing an important role in cell interactions with the matrix. 
 
Biomimetic proteoglycans that mimic natural proteoglycan structure were synthesized in 
the Drexel Biomaterials Laboratory and consisted of a biologically inert polyacrylic acid 
(PAA) core and natural chondroitin sulfate bristles. This novel macromolecule was used 
to determine the influence of matrix chondroitin sulfate proteoglycans found in tumor 
microenvironments on interstitial flow-induced invasion through an in vitro 3D invasion 
assay. Characterization of the in vitro environment was done to quantify changes in 
matrix permeability, as well as qualitatively assess structural and morphological changes 
of the collagen fiber network and melanoma cells. We proposed that the presence of these 
biomimetic chondroitin sulfate proteoglycans (with PAA core molecular weights of 10 
and 250 kDa) would decrease the permeability of the matrix and lead to greater flow-
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induced invasion of melanoma cells due to growth factor binding to the chondroitin 
sulfate side chains, thereby promoting formation of a chemokine gradient. Lower 
concentrations of biomimetic proteoglycans increased matrix permeability and 
dramatically altered collagen fiber matrix structure; however, there was no effect on 
invasion of melanoma cells. High concentrations (≥20mg/ml) of biomimetic 
proteoglycans had no effect on collagen matrix permeability, but the 250 kDa core 
proteoglycan increased flow-induced invasion compared to the 10 kDa core 
proteoglycan. The significant differences in matrix structure may be the cause of the 
increase in permeability when biomimetic proteoglycans were present in the matrices. 
The difference in flow-induced invasion between the two sizes of biomimetic 
proteoglycans led us to hypothesize that the size of the proteoglycan and the degree of 
chondroitin sulfate decoration impacts invasive characteristics of melanoma cells through 
growth factor binding. These studies have advanced the possibility of using these 
biomimetic proteoglycans to generate more defined in vitro matrix microenvironments. 
Moving forward, using biomimetic proteoglycans to better mimic the tumor 
microenvironment can help determine how a multitude of factors influence cellular 
behavior and disease progression. 
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Overview 
Research Objective 
 
One of the major challenges facing cancer researchers, clinicians, and patients is 
understanding and treating invasive and metastatic cancer.  Understanding cancer 
invasion and metastasis on a cellular level involves determining the role of the tumor 
microenvironment. This objective of this study was to understand the contribution of 
matrix proteoglycans to interstitial flow-induced invasion of cancer cells by applying 
novel biomimetic proteoglycans in an in vitro tumor microenvironment model.  
Proteoglycans affect the local tumor niche and play a crucial role in cancer cell biology.  
 
Specific Aim #1: To determine the effect of biomimetic proteoglycans on matrix 
permeability and cell/matrix morphology  
The extracellular matrix plays an important role in cancer biology and the regulation of 
cellular behavior within their environment. The addition of controlled components such 
as biomimetic proteoglycans into the improved microenvironment system would create a 
regulated in vitro matrix to study invasion of melanoma cells. We hypothesized that the 
presence of biomimetic proteoglycans in our modified system would decrease the 
permeability of the matrix, due to the high osmotic pressure that they exert. Due to this 
addition, we also hypothesized that the biomimetic proteoglycans would not affect the 
matrix structurally since these molecules are present within the in vivo 
microenvironment. Both of these hypotheses would be pursued by using the method of an 
in vitro invasion assay to that would mimic a physiological interstitial flow environment. 
Flow was measured at time intervals and the flow velocity and permeability would be 
determined quantitatively. Confocal fluorescence and reflectance microscopy was used to 
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characterize matrix and cell morphology of collagen gels containing the biomimetic 
proteoglycans. This would enable us to understand the morphological similarities 
between the in vitro environments being tested to the in vivo environment. 
 
Specific Aim #2: To determine the effect of biomimetic proteoglycans on interstitial flow-
induced invasion of melanoma cells.  
There are various biophysical and biomechanical forces exhibited in a tumor niche that 
causes the transition from normal to a tumor-like tissue. One concept that is still being 
studied is the importance of interstitial flow and interstitial fluid pressure that causes 
migration and invasion of cancer cells. This invasive behavior may be due to biological 
interactions between cancer cells and matrix proteins, supporting a chemotactic gradient 
that leads to invasion. We hypothesized that the invasion of melanoma-type cancer cells 
would be greater when exposed to interstitial flow in the presence of biomimetic 
chondroitin sulfate proteoglycans due to growth factor binding to the chondroitin sulfate 
side chains.  Interstitial flow-induced invasion was quantified through a 24 h invasion 
assay in the presence of varying concentrations and molecular weights of biomimetic 
proteoglycans. 
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Chapter 1. INTRODUCTION 
 
Current Problem 
 
Local microenvironments play a crucial role in cancer biology and the regulation of 
cellular behavior. Currently, a challenge that remains poorly understood is the role of the 
extracellular matrix in the transition from normal physiology to a cancerous niche. 
Cancer is one of the leading causes to death globally and 7.6 million deaths have 
occurred in 2008 [1]. More specifically, there were over 65,000 melanoma-associated 
deaths worldwide in the year of 2000 [2]. The chances to increased survival are through 
early detection of cancer. During diagnosis of cancer, invasion and metastasis are one of 
the most inevitable consequences, which can lead to life-threatening circumstances. 
Although screening techniques have improved through the years, 30% of cancers still 
have detected metastasis [3].  Understanding cancer invasion and metastasis on a cellular 
level involves determining the role of the tumor microenvironment. This study would like 
to explore the interaction between the modified biomimetic proteoglycan extracellular 
matrix and interstitial flow-induced invasion of melanoma cells. 
Cancer Biology  
 
Cancer remains a challenge to understand due to the complicated signaling pathways 
involved that trigger the transition from a normal to cancerous cell. Cancer is a disease of 
abnormal cell growth, which can lead to uncontrolled proliferation originating from a 
single abnormal cell with mutated DNA. Tumor mass formation is developed through 
multiple rounds of mutation and expansion leading to progressively aberrant stages [4, 5]. 
Cancer cell transformation occurs from normal to cancerous through induction of 
oncogenes [6]. Normal cells contain proto-oncogenes, which can be transformed to 
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oncogenes through genetic alteration. Oncogenes are typically proteins involved with cell 
proliferation and growth through regulation of the cell cycle [7]. These cells create their 
own control circuit to promote signal transduction for sustained growth and proliferation 
between the cell and it’s extracellular matrix with the help of integrins and focal 
adhesions. Proliferation in a limited space leads to the disruption of tissue organization 
[6, 8]. This disruption of the tissue leads to aberrant stage of cancer and one of the major 
cancers affecting a population globally is melanoma.  
Melanoma 
Cancer is one of the leading causes of death worldwide. More specifically, one of the 
most prominent cancers today is melanoma. In 2013 in the United States, an estimate of 
76,690 men and women are diagnosed with melanoma and approximately 9,480 will die 
of melanoma.  The survival rate for localized disease is 98.3%, for regional disease 
(when spread to the lymph nodes) is 62.4%, and for metastatic disease is 16% [9, 10]. 
There are several signs for detecting melanoma, which include changes in size, shape, 
and color of a mole or new skin lesion.  Melanoma is a small and mole-like growth or 
skin lesion, which increases in size with varied discoloration. Method of detection is 
through an “ABCD” rule where: 1.“A” for asymmetry of the lesion, 2.“B” for the 
irregular border of the lesion, 3. “C” for color or discoloration, and 4.“D” for the 
diameter of the lesion. Melanoma lesions tend to be uneven at the edges, have non-
uniform pigmentation, and are greater than 6 mm in width. Early detection of these 
lesions is a key factor to a higher survival rate. Once detected, melanoma is treated 
through various modalities [10]. First, a new skin lesion or mole can be removed via 
surgical excision, electrodessication and curettage, or cryosurgery. Electrodessication and 
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curettage is a procedure performed by dermatologists where the tissue is degraded 
through an electric current and then abraded by a curette. Cryosurgery is another removal 
procedure of the local lesion via freezing [10, 11]. Other methods of treatment include: 
radiation therapy, topical medications, immunotherapy, chemotherapy, and surgical 
excision of the tumor, surrounding normal tissue, and lymph nodes involved. Surgical 
excision and other previously mentioned modalities are used when the cancer is detected 
in later stages. Currently, there are two FDA approved drugs for treating advanced stage 
melanoma: vemurafenib, which targets the BRAFV600E kinase mutation [12], and 
ipilimumab, which is an immunotherapy drug [10]. Ipilimumab is a monoclonal antibody 
which binds to cytotoxic T-lymphocyte-associated antigen 4 and is effective through 
ligand blocking which can increase an immune response through T- activation and 
proliferation of T-cells [13].  As one can see, many researchers are targeting the tumor 
microenvironment and the cellular signaling pathways that are associated with cancer in 
order to come up with a solution this this problem.  
Interstitial Flow and Cancer 
 
The tumor microenvironment plays a crucial role on cellular behavior and the factors 
within the extracellular matrix (ECM). The tumor microenvironment is composed of the 
ECM, various cell types (tumor, epithelial, immune, and fibroblasts), and soluble factors 
[14, 15].  Physical changes in the tumor microenvironment can enhance tumor 
progression because of increased stress due to tumor growth, increased stiffness, elevated 
interstitial fluid pressure, and increased interstitial fluid flow. The matrix tends to 
increase in stiffness when transitioning to a cancerous niche due to an increase in stromal 
tissue [14, 16, 17]. With the increase in stiffness of the ECM, there is enhanced cell 
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growth and migration due to increased cell tension [14, 18].  Since there is a proliferation 
of cells in a restricted environment, this leads to increased stresses in the tumor and 
surrounding tissue [14, 19]. These increased stresses affect the tumor physiology, there 
by leading to an abnormal interstitial environment. Initially, the tumor receives oxygen 
and nutrients provided by pre-existing vessels local to the site [20]. However, an increase 
in proliferation of cells within the space leads to hypoxia. This hypoxia upregulates 
vascular endothelial growth factor (VEGF) and other factors to initiate angiogenesis. 
Newly formed blood vessels have a higher permeability allowing fluid and 
macromolecules to easily enter thereby leading to an increase in interstitial fluid pressure 
[14, 20]. This elevated pressure simultaneously increases lymphangiogenesis and the 
formation of lymphatic capillaries. Both of these create an increased fluid flux, which is 
known as interstitial fluid flow. Interstitial fluid flow affects the cells within the tumor 
exposing them to fluid shear stress and creating pericellular cytokine gradients [21]. 
These cytokine gradients are sometimes associated with chemotaxis, which is directed 
cell migration due to a soluble chemical gradient [14]. Chemotaxis is often driven by 
chemokines, which are small proteins that interact with G-protein coupled receptors 
(chemokine receptors) and induce directed migration, among many other behaviors [22]. 
A chemokine receptor that is common to most cancers is CXCR4 [23]. More specifically 
the chemokine receptors involved in melanoma progression are CXCR3 and CXCR4 [24-
26]. The homeostatic chemokine, CXCL12, that is expressed in skin binds to the 
chemokine receptor CXCR4. CXCR4 is expressed in endothelial cells or pericytes that 
are undergoing a pathological change such as hypoxic conditions within the tumor. 
Therefore the CXCL12/CXCR4 pathway plays a role in melanoma through the 
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progression of angiogenesis and metastasis [27]. On a micro-level, CCL21 is a 
chemokine, that binds to the sulfated glycosaminoglycans, thereby recruiting immune 
cells and creating this gradient [21]. Interstitial flow induces melanoma cells invasion 
(MDA-MB-435s,) via CCR7/CCL21 through a mechanism known as chemotaxis [14, 
28]. The tumor cells secrete this chemokine creating a slight concentration gradient and 
tumor cells that have this receptor can respond by chemotactically migrating in the 
direction of interstitial flow. Interstitial fluid flows away from the higher pressure tumor 
and towards the lower pressure draining lymphatic vessels, which could promote invasion 
into the lymphatic system[14].  Hence, interstitial fluid flow plays an important role in 
the extracellular matrix leading to the beginning of invasion from local environment to 
metastasis. 
Extracellular Matrix 
 
The extracellular matrix and stroma play a key role in cancer biology and can affect cell 
behavior. Stroma acts as a supportive structure for organs. It is composed of the 
extracellular matrix, which includes insoluble matrix molecules: fibrous proteins, 
proteoglycans, hyaluronic acid, and stromal cells that vary in physical and biological 
functions. Stromal cells include: mesenchymal, endothelial, pericellular, and immune 
cells. Within the extracellular matrix there are various soluble factors such as proteins 
(chemokines, cytokines, growth factors, and antibodies) and metabolites [29, 30]. 
Structurally, it is composed of two compartments: the basement membrane and interstitial 
matrix. The basement membrane is composed of matrix proteins that organize the 
epithelium and separate the epithelial cells from the stroma. The basement membrane is 
compact and porous. It consists of other macromolecules such as collagen type IV, 
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laminin, fibronectin, and linker proteins such as nidogen and entactin. These linker 
proteins help connect the collagen with other molecules within this compartment. The 
second part of the extracellular matrix, the interstitial matrix, is composed of stromal 
cells, fibrillar collagens, proteoglycans, and glycoproteins such as tenascin-C and 
fibronectin. This compartment contributes to the strength of tissues [29]. 
 
 
 
 
Figure 1: The extracellular matrix differences between normal and tumor niches [31] The image 
above depicts the transition between a normal tissue to tumor tissue and the changes that occur during 
this transition. An increase in extracellular matrix molecules, such as proteoglycans is the key 
component to notice in this figure. 
 
 
 
Both of these structural components influence the environment functionally, through 
changes in biophysical, biomechanical, and biochemical properties. The biophysical 
properties control tissue architecture and affect cell migration through porosity, rigidity, 
topography, and solubility [29, 32]. Biomechanical properties help determine the nature 
of the tissue, regardless of whether it is in a normal or diseased state. The main 
component of determining this is the elasticity or stiffness of the matrix. The stiffness of 
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the matrix can affect cell behavior and contribute to disease development [29, 33]. A 
change in mechanical force can lead to the activation of signaling pathways. Also, 
biomechanical properties can affect cell fate, differentiation, migration, and tissue 
function [29, 34]  The architecture of the matrix changes when transitioning to a 
cancerous niche. For instance, the basement membrane breaches and myoepithelial cells 
produce tumor-suppressing features that suppress the production of laminin. Both of 
these characteristics occur as the cancer progresses. Also, changes in the interstitial 
matrix are prominent during this transition.  As mentioned previously, the interstitial 
matrix provides strength and support to the tissue and also provides biochemical 
interactions such as chemokine and growth factor binding. During this transition, there is 
a remodeling of the matrix and specifically of collagen type I. There is an increase in the 
amount of fibrillar collagen type I and the structure changes to a more linear and 
perpendicular alignment to the tumor border [30, 35]. Furthermore, the biomechanical 
properties, such as increase in stiffness occur with fibrillar collagen type I. Collagen and 
fibronectin have a strong relationship within the tumor environment. Fibronectin 
maintains the collagen fiber organization through binding to collagen. When stretching of 
fibronectin occurs in the environment, it leads to fibrillogenesis and an increase in 
rigidity [36].  Also, cell adhesion molecules play a crucial role in the function of the 
extracellular matrix, providing a network for the cells to bind to the ECM. For instance, 
the focal adhesion complex enables the cells acto-cytoskeleton to bind to the matrix 
through mechanosensing [29]. Biochemical properties are based on signaling within and 
outside of cells. These properties help us understand cell-cell and cell-matrix interaction. 
Changes in the environment lead to changes in cellular behavior [29, 32]. 
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Properties of the extracellular matrix are dependent on one another. Hence, when the 
matrix becomes stiffer, this affects the biochemical properties through initiation of 
signaling pathways, and therefore affects a cell’s ability to migrate through the matrix.  
The extracellular matrix can remodel over time by changing its composition.  The cell-
ECM interaction is similar to a feedback loop, allowing both the matrix and the cells to 
be dependent on one another. Therefore, the cells and matrix adapt to each other by 
creating and rearranging their environment [29].  
The extracellular matrix is remodeled through matrix enzymes that can be altered through 
abnormal metabolism by cancer-associated fibroblasts from the stroma and immune cells. 
The hallmark characteristic of an abnormal extracellular matrix is that it can change the 
dynamics of its environment. These changes include: an increase in deposition of various 
collagens (collagen I, II, III, V, and IX), an increase in MMP activity, overproduction of 
CD44 and heparin sulfate proteoglycans, and physical changes such as increased stiffness 
[29].  The loss of connection to cell adhesion molecules can be associated with invasion. 
Hence cell polarity regulates its interaction with the surrounding environment through 
integrins [3]. The biochemical changes leading to an up regulation of integrin signaling 
pathways can initiate and promote cell proliferation and survival [29].  
Proteoglycans 
 
One of the hallmarks to the transition into an abnormal environment is the increase in 
proteoglycan production. Proteoglycans are one of the three most abundantly found 
molecules in the extracellular matrix. They are anionic molecules that are located within 
the matrix or on the cell’s surface. They provide structural integrity, regulate cellular 
processes, and are one of the key bioactive molecules. Some of their functions include 
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regulation of cell proliferation, differentiation, and migration. A proteoglycan is 
composed of a protein core and a variable number of glycosaminoglycan (GAG) side 
chains. Glycosaminoglycans are linear polysaccharides comprising of 4 different sulfate 
subsets: chondroitin, dermatin, heparin, and keratin [37]. 
The proteoglycans of interest in this study are chondroitin sulfate (CS) proteoglycans, 
which consist of anionic linear polysaccharide CS chains covalently attached to the 
protein core. There are various types of CS proteoglycans, which include: aggrecan, 
found in cartilage, versican, found in non-cartilaginous tissue, and the small leucine rich 
proteoglycans decorin and biglycan [37]. Aggrecan and versican are highly decorated 
with both keratin sulfate and chondroitin sulfate side chains, having a structure similar of 
a bottlebrush. The unique aspect about the chondroitin sulfate chains is that they are 
biologically functional through interaction with the saccharide domains between various 
molecules in their environment such as growth factors, cytokines, chemokines, adhesion 
molecules, and lipoproteins [37]. 
One chondroitin sulfate proteoglycan, versican, is typically found in soft tissues, 
primarily skin. It is a large extracellular matrix proteoglycan with a molecular mass 
greater than 1000kDa and has the ability to bind to hyaluronan.  
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Figure 2: Versican structure[38] 
 
 
 
Its structure consists of a N-terminus glycosaminoglycan binding region, a protein core, 
and a C-terminus. The N-terminus plays a role in maintaining the integrity of the ECM 
through interaction with hyaluronan. The core protein is encoded by two large exons that 
specifically attach to chondroitin sulfate, exon 7 (alpha-GAG) and exon 8 (beta-GAG). 
The C-terminus plays an important role in interacting with a number of molecules in the 
matrix. There are 4 mRNA transcripts that are made through splicing that can 
differentiate into different isoform such as: V0, V1, V2, and V3. Skin has mRNA 
isoforms of V0 and V1 [39].  Versican interacts with various molecules within the matrix 
through protein-protein or protein-carbohydrate interactions. The protein-protein 
interaction between the amino terminus of the GAG and hyaluronan occurs through the 
G1 domain in the ECM, creating a double loop of 5 repeating disaccharides. Also, 
versican can interact through protein-carbohydrate binding with tenascin R via the lectin-
binding domain. It can interact with fibrillin, which would allow for the binding to 
fibulin-2 to co-localize the elastic fibers. All three interactions show that these 
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proteoglycans can interact through structurally binding to various parts of the 
extracellular matrix [39]. 
In cancer, it is known that there is an increase in production of proteoglycans. 
Chondroitin sulfate proteoglycans tend to accumulate in tumor stroma and are involved in 
tumor growth and invasion. There is an increase in expression of CS proteoglycans in 
rapidly growing tissues. Chondroitin sulfate plays a role in tumorigenesis in that the 
negatively charged CS chains interact with ligands and receptors, which leads to the 
activation of signaling pathways that stimulate tumor growth. There is a greater amount 
of versican expression seen in tumors such as breast and malignant melanoma [37]. 
Versican can promote cell motility and invasion. When looking at it from a molecular 
scale, isoforms V0 and V1 are found in malignant melanoma and contribute to increased 
cell proliferation rate and decreased cell adhesion of tumor cells [40, 41]. The globular 
domains, G1 and G3, promote cell proliferation of tumor cells. This is seen by G1 
stimulating proliferation through the destabilization of cell adhesion [42].  Similarly, the 
G3 domain induces proliferation through the activation of epidermal growth factor 
receptors [41, 43]. 
Biomimetic Proteoglycans 
 
One of the challenges in studying the role of proteoglycans in the tumor 
microenvironment is their functional diversity, as evidenced above in the case of 
versican. Another challenge is that it is difficult and costly to isolate and purify 
proteoglycans, even large species such as aggrecan and versican.  A potential strategy for 
addressing these challenges is to use biomimetic proteoglycans, which provide some or 
all of the biological activity of natural proteoglycans, but are synthesized in a laboratory 
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and allow for greater control of the characteristics of the proteoglycan and improved 
yields.  The biomimetic chondroitin sulfate proteoglycans (bCSPGs) used in this study 
mimic the structure of a proteoglycan by having a biologically inert core covalently 
bound to chondroitin sulfate (CS) side chains. Since the core of the molecule is composed 
of polyacrylic acid (PAA) rather than a protein core, the cells cannot biologically interact 
with this component of the molecule. This allows for the specific examination of the role 
of the biologically active CS side chains. Two different biomimetic proteoglycans are 
used in this study, with PAA cores of 250kDa and 10kDa (personal communications with 
Dr. Prudnikova, 2013). The 250kDa bCSPG is similar in structure to versican as its total 
molecular weight and total amount of CS bristles is approximately the same. The core 
molecular weight for the 250kDa is within the range of biological versican, 200-400kDa. 
The biomimetic 250kDa proteoglycan is greater in the amount of chondroitin sulfate 
bristles than versican. This molecule has approximately 80 chondroitin sulfate bristles 
which is slightly less to the amount of bristles attached to aggrecan’s core, 100-150 side 
chains [42]. Both molecular weight biomimetic proteoglycans are synthesized through 
the attachment of CS to the terminal amine group of the PAA core with a release of water 
or HCL (personal communications with Dr. Prudnikova, 2013).  
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Figure 3: Biomimetic Proteoglycans, 250kDa and 10kDa Structure: The above image depicts both 
molecular weight biomimetic proteoglycans at a molecular and physical structure. The molecular 
structure shows how the chondroitin sulfate side chain attaches to polyacryclic acid core. This picture 
was given by Dr. Katsiaryna Prudnikova (Courtesy K. Prudnikova) 
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Chapter 2. METHODS 
Approach 
The objective of this study was to determine the influence of biomimetic proteoglycans 
on the tumor microenvironment and their effect on interstitial flow-induced invasion of 
melanoma cells. The primary outcome indicators used were cell invasion, matrix 
permeability, and cell/matrix morphology. These three components were tested using a 
variety of methods including invasion assay, quantitative measurements and calculation 
of permeability using Darcy’s law, confocal fluorescence microscopy and confocal 
reflectance microscopy of varied in vitro microenvironments.  Characterization of the 
matrix system was in parallel with quantification of the invasive characteristics of 
melanoma cells through the modified in vitro matrices. 
 
Cell Culture 
This study used the metastatic melanoma cell line MDA-MB-435S [44-46]. These cells 
were cultured in a 2D environment in T-25 flasks and used at passages 4-12. They were 
maintained at 37°C, 5% CO2, in Dulbecco’s modified Eagles medium (DMEM 1X) with 
10% fetal bovine serum and 1% penicillin-streptomycin. 
Biomimetic Chondroitin Sulfate Proteoglycans 
Biomimetic chondroitin sulfate proteoglycans was graciously provided by Dr. Michele 
Marcolongo’s lab. The biomimetic molecules were synthesized and processed by their 
post-doctoral fellow, Dr. Katsiaryna Prudnikova.  The biomimetic bCPSGs produced 
were of two different molecular weight cores, 250kDa and 10kDa. The bCSPG molecule 
is composed of a polyacrylic acid (PAA) core and chondroitin sulfate (CS) bristles. The 
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total molecular weight of the 250kDa molecule is 2010kDa since the PAA core is 
250kDa and the 80 CS bristles are 22kDa each. Each molecule is synthesized with 1 CS 
attached to every 45 amino acid functional groups. CS is attached to terminal NH2 
through the release of a water molecule. Therefore, there are approximately 77 CS 
bristles to each 250kDa molecule. The 10kDa bCSPG is a smaller molecule and has a 
total molecular weight of 230kDa consisting of a core that is10kDa and 10 CS bristles of 
22kDa each. Approximately 96% of the molecule is composed of CS. These molecules 
are synthesized as 1 CS to every 10 amino acid functional groups yielding ~10-11 CS 
bristles to each 10kDa core molecule. The CS is attached to terminal NH2 through the 
release of an HCl molecule (personal communications with Dr. Prudnikova, 2013). 
3-D Flow Invasion Assay 
 
A modified Boyden chamber invasion assay was used to determine the influence of 
matrix proteoglycans involved in tumor microenvironment and their effect on interstitial 
flow-induced invasion [47]. MDA-MB-435s cells, were suspended in a 1.3 mg/ml rat tail 
collagen I (BD Biosciences), 0.5 mg/ml Matrigel (BD Biosciences), 10X PBS, sterile 
deionized water, sodium hydroxide (NaOH), and 10kDa or 250kDA bCSPG. Also, 
control studies were done using free chondroitin sulfate and polyacrylic acid. These 
components were added to the gel in a similar manner to the bCSPG’s. Since rat-tail 
collagen type I tends to be acidic, sodium hydroxide (NaOH) and 10X PBS was added to 
neutralize the system. Also, sterile deionized water was added as a filler to increase the 
amount of gel. For some of the experiments, Matrigel was removed and replaced with 
varying concentrations of bCSPG. Hence the conditions for the various 
microenvironments are: 1. Matrigel + collagen (Matrigel), 2. collagen-only, 3. collagen + 
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250kDa bCSPG, and 4. collagen + 10kDa bCSPG. The concentrations of Matrigel and 
collagen-only conditions remained constant throughout the study. The concentration of 
Matrigel used was 1mg/ml (stock concentration: 9mg/ml). The concentration of collagen 
used was 1.3 mg/ml (stock concentration carried from 4.41-4.73 mg.ml). The 
concentration of biomimetic molecules changed with each experiment and is specified in 
the results per study. In order to remain consistent, the tumor cell density for experiments 
was at 5.2 x 105 cells/ml. The cells at the specific concentration mentioned above were 
added to the collagen mixture after 1 h incubation on ice. The cell-ECM mixture was then 
pipetted into 8µm pore transwell culture inserts (Millipore). After a 30 minute gelation 
period at 37°C, 5% CO2, DMEM 1X basal media was added to each transwell dependent 
on the condition. In order to create a physiologically relevant interstitial flow 
environment, static and flow conditions were placed for each transwell per condition. The 
static condition had 100µL above the gel of the transwell and 650µL below the transwell 
within the 12-well plate. The flow condition had the exact opposite volumes to the static 
condition, 650µL above transwell and 100µL below transwell (Fig. 4).  Flow through the 
transwell was measured at a 30-minute time point from the initial point of adding media 
to the flow transwells. The invasion assay was incubated at 37°C and 5% CO2 for 24 
hours.  After 24 hours the membrane of the transwell was fixed through DAPI staining in 
a 24-well tissue culture plate. DAPI stained for the nucleus of the cell in order to decipher 
cells through imaging. The fixed membranes were imaged through fluorescence 
microscopy. The membranes were stained for DAPI to decipher the tumor cells. Once 
each membrane was imaged, cell count was taken per membrane, and the percent 
invasion was calculated through Excel. The total was calculated as the (membrane 
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area/image area)*average number of cells counted per 5 images taken. The percent 
invasion was calculated as the (invaded cells/total cells seeded)*100.  
 
 
 
 
Figure 4: 3-D in vitro invasion assay method [47]. 	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Flow Study and Gel Permeability Analysis 
Characterization of the in vitro system was done by altering the composition of the matrix 
through elimination of Matrigel and addition of bCSPGs. The conditions used were 
collagen + Matrigel, collagen only, collagen + 10kDa bCSPG, and collagen + 250kDa 
bCSPG. Permeabilities for each matrix type was calculated quantitatively through flow 
measurements (flow velocity) and the use of Darcy’s Law.   
Flow measurements were taken at specific time intervals 30 minutes, 1 hour, 2 hours, and 
4 hours after onset of flow. Flow was measured through pipetting the remainder of the 
basal media left in the 12-well plate and subtracting the initially added 100µL volume 
from that value.   
From the volume measurements (uL), flow velocities were calculated by assuming 
constant flow rate through a given cross-sectional area. The flow rate was the amount of 
volume eluted through the gel over time. An example of flow velocity calculations is 
shown below.  
 
Table 1: Flow Velocity Example calculation through Excel to later determine the permeability  
 
Condition Vol. 
left 
Vol. 
Eluted 
(uL) 
Vol. 
(cm3) 
Vol. 
(um3) 
Time 
(sec) 
Area 
(um2) 
Flow 
Rate 
(uL/sec) 
Flow Rate 
(um3/sec) 
Flow 
Velocity 
(um/sec) 
Collagen  250 400 0.4 4 x1011 1800 60000000 0.2222 222222222.2 3.704 
 
 
Using the measured average flow rate Q, the permeability k was calculated through 
Darcy’s Law.  The permeability was calculated using the equation shown below and the 
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variables are shown in the schematic of the transwells. The permeability values are 
presented in units of cm2.  
 
 
 
 
Figure 5: Quantitative method for determining gel permeability 
 
 
 
Confocal Microscopy: Cell Morphology and Collagen Fiber Morphology 
 
The collagen and collagen + bCSPG gels were fixed and stained within a glass bottom 
chamber slide and were imaged through confocal microscopy. For the initial experiment, 
the gels were fixed and stained with conjugated phalloidin and DAPI. The collagen gel 
was synthesized using the same method of creating gels for the invasion assay. Both 
conditions were pipetted into an 8-chamber or 4-chamber glass bottom chamber plate and 
is incubated for 30 minutes at 37°C. Once the mix had formed a gel within the chamber 
plate, it was ready for microscopy. For confocal reflectance microscopy, samples were 
illuminated with a 488 nm laser and the reflected light was detected on the confocal 
microscope using a 480 – 495 nm bandpass filter.  In some cases, cells (if present) were 
k:  permeability of matrix 
Q: volumetric flow rates 
µ : viscosity of H2O at 37°C 
L: thickness of the transwell 
A: cross-sectional area of matrix 
Pb- Pa= ρgh (hydrostatic pressure head) 
k = 
QµL 
A (Pb- Pa) 
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counterstained with Alexa Fluor 488-conjugated phalloidin (to visualize F-actin) and 
DAPI (to visualize cell nuclei).     
Imaging of fluorescently tagged melanoma cells within collagen gels 
The goal was to understand cell morphology and collagen fiber morphology changes in 
each in vitro microenvironment. From the previous assay, it was determined that the gels 
containing bCSPG did not form gels therefore, fixing and staining the gel was rather 
difficult. Hence, another method to staining the cells without fixing them was done by 
fluorescently tagging the melanoma cells with cell tracker red dye (Invitrogen) prior to 
addition into the collagen-only and collagen +bCSPG gels. This stain was the cell tracker 
red fluorescent protein dye, which stained for the cell’s cytosol.  
Imaging of acellular gels 
 
The goal was to understand structural change in collagen fibers between various in vitro 
microenvironments. The gels were composed of collagen-only, collagen + 250kDa 
bCSPG, and collagen + 10kDa BCSPG. Each gel was synthesized using the same method 
from creating gels for an invasion assay. These gels were placed in 4-chamber or 8-
chamber glass bottom plates. Collagen fiber imaging was captured through confocal 
reflectance, which is mentioned above, except that no cells were present and the gels 
were not fixed prior to imaging.  
Data and Statistical Analysis 
 
All data are presented as means ± standard error of the mean (SEM). Statistical analysis 
was done with GraphPad Prism where the invasion and permeability data was analyzed 
by t-test or ANOVA to determine significance (p < 0.05).  If differences were identified 
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by ANOVA, a Tukey’s test was performed to determine differences between specific 
conditions. 
 
 
 
 
 
 	  	  	  	  
	  24	  
Chapter 3. RESULTS 
 
The goal of this study was to understand the influence of biomimetic proteoglycans 
within the extracellular matrix by specifically looking at three main findings: matrix 
permeability, cell and matrix morphology, and melanoma cell invasion through the 
matrix. Biomimetic proteoglycans have a biologically inert core with chondroitin sulfate 
side chains or bristles. Using a biomimetic is advantageous to this study as the core of the 
molecule is composed of polyacrylic acid (PAA) rather than a protein core, allowing the 
cells to interact solely with the biological component, chondroitin sulfate side chain, 
thereby acting as a control.  
Matrix Permeability 
The lower concentrations of bCSPG were tested to understand their effects on 
permeability of the matrix. The bCSPG gels were compared to the Matrigel and the 
collagen-only conditions. We hypothesized that addition of lower concentrations of both 
250kDa and 10kDa bCSPG would decrease the permeability of the matrix. However, 
lower concentrations of both the 10kDa and 250kDa bCSPG gels exhibited similar 
permeabilities to the collagen-only gel.  As expected, the matrix containing Matrigel 
exhibited a significantly lower permeability (Fig. 6).  
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Figure 6: Collagen gels containing low concentrations of either 10 kDa or 250 kDa bCSPGs exhibit 
similar permeabilities to one another and to the collagen only matrix. The flow measurements were 
taken at the two-hour time point. Hence these permeability measurements were based on fluid flow 
over a time span of two hours. Statistical significance was seen between Matrigel + collagen and 
collagen only matrix (p <0.01). 
 
 
 
There was no permeability change between the collagen-only matrix and the collagen 
gels that contained low concentrations of both 10kDa and 250kDa bCSPG, using 
measurements based on 2 h of flow (Figure 6).  
Later, flow was measured at a 30-minute time point, as we observed that flow rate 
decreased rapidly over time (due to the decreased hydrostatic pressure head).  Thus, 
measuring flow rates at an early time point would yield the most accurate estimation of 
matrix permeability. Results showed that there was a statistically significant increase in 
permeability when the 250kDa bCSPG was present in the gel when compared to the two 
controls, Matrigel and collagen-only (Fig. 7).  
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Figure 7: There is a prominent difference in matrix permeabilities between all three conditions after 
30 minutes into the invasion assay. The flow measurements were taken at the thirty-minute time point. 
Hence these permeability measurements were based on fluid flow over a time span of thirty minutes. 
The matrix permeability shows statistical significance in: Matrigel + collagen to collagen (p  <0.001), 
Matrigel + collagen and collagen + 250kDa bCSPG (p < 0.001), and between collagen and collagen + 
250 bCSPG (p < 0.05).  
 
 
 
Since the lower concentrations did not affect the permeability of the matrix initially, a 
higher concentration was tested at 60mg/ml. A permeability of 20mg/ml was tested for 
both molecular weight proteoglycans however, the time point that flow was measured at 
was 24 hours. These results showed an increase in matrix permeability for both 10kDa 
and 250kDa when compared to the Matrigel condition (Appendix I). The goal was to 
determine whether there was decreased permeability of the matrix when higher 
concentrations of both the 250kDa and 10kDa bCSPG were present in the matrix.  
The three different matrix types that were tested included: Matrigel, collagen-only, and 
collagen + 250kDa bCSPG. A difference in gel permeability was seen between the 
Matrigel and the other two conditions (Fig. 8).  
0
2×10-9
4×10-9
6×10-9
8×10-9
1×10-8
Pe
rm
ea
bi
lit
y 
(c
m
2 )
250kDa bCSPG (mg/ml)
Matrigel Collagen
- - 1
***
***
*
	  27	  
          
Figure 8: Matrix permeability differences are seen when compared to the Matrigel matrix. The flow 
measurements were taken at the thirty-minute time point. Hence these permeability measurements 
were based on fluid flow over a time span of thirty minutes. There was a statistical significance 
between these two conditions of Matrigel + collagen and collagen only (p <0.01) and Matrigel and 
collagen + 250kDa bCSPG (p <0.001). 
  
 
 
Individual components that composed the biomimetic proteoglycans were also tested as 
controls to understand their effects on matrix permeability. The individual components 
included free chondroitin sulfate and polyacrylic acid. These gels were compared to the 
collagen only gels.  
The free chondroitin sulfate individual component was tested. The range of free 
chondroitin sulfate was determined by the higher bCSPG concentration condition of 
20mg/ml. Structurally, we know the percent chondroitin sulfate on the bCSPG molecule. 
Therefore, for 250 kDa, 80% is composed of chondroitin sulfate and for 10kDa, 96% is 
composed of chondroitin sulfate. Hence values ranged from 8mg/ml to 40mg/ml.  
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Figure 9: The free chondroitin sulfate shows a decreased permeability as the concentration increases. 
The flow measurements were taken at the thirty-minute time point. Hence these permeability 
measurements were based on fluid flow over a time span of thirty minutes. This is statistically shown 
by the difference in matrix permeability between collagen only and the 8mg/ml, 15mg/ml, and 25 
mg/ml free chondroitin sulfate matrices (p<0.01). 
 
 
 
Results show an increase in permeability when adding free chondroitin sulfate to the 
system at concentrations of 8mg/ml, 15mg/ml and 25mg/ml (Fig. 9). These values fall 
under the range of the 20 mg/ml for both the 10kDa and 250kDa bCSPG, more 
specifically between 15-25 mg/ml.  
Another individual component of the bCSPG tested was polyacrylic acid. The polyacrylic 
acid concentrations were chosen from lowest concentration to highest concentration 
dependent on the percent concentration within each molecular weight bCSPG molecule. 
In a 10kDa bCSPG, 4% is composed of PAA, while in a 250kDa bCSPG, 20% is 
composed of PAA respectively. Therefore, concentrations were calculated using the 
20mg/ml concentration and the range was determined to be between 0.8mg/ml to 4 
mg/ml.  
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Figure 10: An increase in matrix permeability is seen in gels containing a higher amount of 
polyacrylic acid. The flow measurements were taken at the thirty-minute time point. Hence these 
permeability measurements were based on fluid flow over a time span of thirty minutes. This 
difference was statistically significant in only the comparison of collagen only and the 2mg/ml and 
4mg/ml PAA gels (p<0.001).  
 
 
 
An increase in permeability was seen in gels that had the higher range of polyacrylic acid 
when compared to the collagen only gel. Also, a slightly higher permeability coefficient 
is seen in the gels with solely polyacrylic acid (Figure 10).  
Collagen Fiber and Cell Morphology 
 
Qualitatively, the gels that had formed above the membrane of the transwell had varied 
physical consistencies. Gels with Matrigel and collagen-only were noted to be thicker 
than those that contained either molecular weight bCSPG, which portrayed a very thin 
film above the membrane. This led to a visual characterization of the cells and collagen 
network using confocal microscopy.  Firstly, the study of collagen fibers and cell 
morphology was an initial goal. This was studied through creating gels in a glass-bottom 
chambered slide where the gels were stained and fixed prior to imaging.  However, a 
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consequence to fixing the gels with bCSPG was that the gels stayed in a liquid form 
making them harder to stain and fix.  
The collagen fiber matrix and melanoma cells were vividly seen in the collagen-only 
matrix. The concentration used for collagen type I and bCSPGs are 1.3mg/ml and 
1mg/ml respectively. These images were produced through confocal reflectance and 
confocal fluorescent microscopy. 
 
              
 
 
 
 
 
  
 
Figure 11: Confocal microscopy was able to show collagen fiber network matrix of the in vitro system. 
The pictures above show the melanoma cells within the collagen fiber matrix.  The top picture shows 
a confocal reflectance image and the bottom shows a merge of the confocal reflectance and 
fluorescence of the melanoma cells stained with DAPI and phalloidin. The picture on the right shows 
a zoomed in view of the collagen matrix. These pictures were taken in 60X under oil immersion 
through confocal microscopy. The fiber structure was imaged through a technique known as confocal 
reflectance.  
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These images show that in a collagen-only gel, the fiber network is densely formed 
throughout the matrix (Figure 11). However, a change in this matrix occurs when the 
addition of bCSPG is added to the system. Qualitatively, the difference between the two 
gels, collagen-only and those with bCSPG, is that no gelation was occurring. As the gels 
remain a liquid, they are harder to stain and fix for microscopy resulting in solely images 
of the collagen + 10kDa bCSPG. This condition showed some cell interaction and fiber 
formation (Figure 12).  
 
 
 
 
Figure 12: The collagen + 10kDa bCSPG gel shows cell interaction and a change in fiber 
morphology. This image is produced through confocal reflectance for imaging of collagen fibers and 
phalloidin fluorescent staining through confocal microscopy.  
 
 
 
The gel that contains the 10kDa bCSPG shows different cellular and fiber morphology 
when compared to the collagen-only gel (Figure 12). There seems to be more cell-cell 
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interaction in the 10kDa bCSPG gel. Also, the fibers seem to be more dense and thicker 
in the matrix.  
Since fixing and staining the gels containing the biomimetics was difficult, a fiber 
morphology study was conducted to understand the differences in matrix structure and 
fiber formation. This study was focused on the differences of collagen fiber morphology 
and how it affected gelation. It showed similar results to the previous study in that the 
collagen-only condition formed a gel. Both the 10kDa and 250kDa bCSPG gels remained 
a viscous liquid within the glass-bottom chamber plate. The collagen-only gel was used 
as a control for this experiment and for the previous morphology study. Similar results 
were obtained for the collagen-only gel having a dense amount of fibers throughout the 
matrix (Figure 11). The collagen + 10kDa bCSPG gel had few fibers dispersed 
throughout the gel but appeared to be floating and clumped to one another. The collagen 
+ 250kDa bCSPG gel was similar to the small molecular weight bCSPG gel in that the 
fibers appeared to be floating and they were in clusters. However, a difference in the 
250kDa bCSPG gel was that there were larger clusters and it was more densely populated 
within the matrix (Figure 13).  Also, the 250kDa bCSPG gel was similar to both the 
collagen-only and 10kDa gel in that the fibers are uniformly distributed such as collagen 
only, however, the fibers are in clusters similar to the 10kDa gel.  
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Figure 13: Collagen fiber morphology and physical properties of the gel change when bCSPG is 
present within the gel. A concentration of 1mg/ml of bCSPG for both molecular weights was used for 
both gels. The collagen only gel displays a highly dense amount of fibers that are uniformly 
distributed throughout the gel (left). The collagen + 10kDa bCSPG gel shows a reduction in the 
amount of fibers within the gel, as well as fiber clump formation that is not uniformly distributed 
(middle). The collagen + 250kDa bCSPG gel shows a uniform distribution of large clusters of fibers 
(right).  
 
 
 
Another key factor of understanding the matrix changes is looking at the differences in 
cell morphology and its physical interaction with the matrix. A significant finding from 
the previous experiment was the changes in fiber morphology. The cells were tagged 
fluorescently with CellTracker Red prior to placement in the gel allowing for a sense of 
both fiber morphology and how the cells interact with the fibers and their shape. Results 
for all three conditions showed that cell shape remained the same. However, the size of 
the cells for the collagen-only and collagen + 250kDa bCSPG gels were larger than the 
             Collagen Only                  Collagen + 10kDa bCSPG           Collagen + 250kDa bCSPG                 
	  34	  
collagen +10kDa bCSPG gel (Figure 14, bottom row).  Furthermore, the matrix physical 
properties remained consistent with the previous experiments showing a more densely 
populated fiber matrix in collagen-only and collagen + 250kDa bCSPG gels (Figure 11 
and 13). The matrices with bCSPG showed a cluster formation of collagen fibrils (Figure 
14). The goal of this study was to locate where the cells were positioned in this clustered 
matrix. Results for both molecular weight bCSPG gels showed that the cells were 
suspended in the gel with no contact to the collagen fibrils.  
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Figure 14: Similar collagen fibril morphology is observed with equivalent cell morphology between 
the 3 varied in vitro  matrices. These images were taken through confocal microscopy to image the 
melanoma cells (red fluorescent protein, 577 absorbance) and through confocal reflectance to image 
the collagen fibers. A concentration of 1mg/ml of bCSPG for both molecular weight was used for both 
gels. Similar collagen fibril morphology results were observed to the previous experiment. Cell shape 
remained consistent through matrix environments.  
 
 
 
Interstitial Flow-Induced Melanoma Invasion 
 
The extracellular matrix plays an important role in cellular invasion. This is an important 
factor in the field of cancer biology and provides the rationale for Aim 2, which is to 
understand the effects of bCSPGs on the invasion of melanoma cells. The biomimetic 
proteoglycan is a unique tool in understanding this aim as it acts as a control that has a 
        Collagen Only                   Collagen + 10kDa bCSPG           Collagen + 250kDa bCSPG                 
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biologically inert core with biologically active side chains. We hypothesize that the 
melanoma cells (MDA-MB-435S) would interact with the chondroitin sulfate side chains 
causing growth factor binding and thereby affecting invasion of these cells through the 
matrix. In order to determine this we performed an in vitro transwell invasion assay that 
would mimic the in vivo environment by creating similar conditions as mentioned 
previously in this section. The various environments that would be created are: Matrigel, 
collagen-only, and collagen + bCSPG of both molecular weights. To mimic the tumor 
microenvironment, a flow condition that has similar physiological flow properties would 
be added to the system in order to determine flow-induced invasion.  
An initial study of understanding the invasive characteristics to this cell line was 
performed. This control study allowed us to analyze whether this cell line is sensitive to 
flow-induced invasion similar to a physiological environment. The microenvironment 
was composed of a Matrigel incorporated with melanoma cells.  
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Figure 15: The melanoma cancer cell line shows sensitivity to flow-induced invasion. Statistical 
significance was shown in invasion between static and flow (p<0.05).  
 
 
 
Results have shown that the melanoma cell line is sensitive to flow-induced invasion. It 
increases almost by 3 fold when comparing the result to the static control condition. 
(Figure 15). This has also been shown in previous studies [14, 48] and is a positive result, 
as it allows one to determine how this cell type would act in varied in vitro tumor 
microenvironments.  
Next, an initial biomimetic proteoglycan versus no proteoglycan study was performed. 
This microenvironment was composed of Matrigel and 250kDa bCSPG. This was done to 
determine whether the addition of biomimetic proteoglycan in the same 
microenvironment would affect invasion.  
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Figure 16: Addition of the 250kDa biomimetic proteoglycan has little to no effect on the same 
microenvironment. Statistical significance was shown between static and flow conditions (p <0.05).  
 
 
 
The addition of the biomimetic proteoglycans to the same microenvironment resulted in 
no difference in invasion (Figure 16). However, a similar result in invasion was seen by 
the difference in static versus flow in each individual condition.  
This in vitro system is mimicking the tumor microenvironment on a smaller scale; hence 
low concentrations of both molecular weight bCSPGs were tested separately.  When 
adding lower concentrations of bCSPG to the in vitro system, there was no change in 
invasion between the control (Matrigel) and the experimental conditions (gels with 
bCSPG) (Figure 17 and 18).  
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Figure 17: Addition of low concentration of 250kDa bCSPG showed little to no effect on interstitial 
flow-induced invasion.  
 
 
 
The 250kDa bCSPG, showed little change in the flow-induced invasion and, the static 
condition decreased in invasion as the presence of bCSPG increased. However, this is not 
statistically significant (Figure 17).   
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Figure 18: Low concentration of 10kDa bCSPG showed no effect on changes in flow-induced 
invasion. However, there was a 3-fold difference in invasion when comparing each condition 
individually (p <0.01).  
 
 
 
The lower concentration 10kDa bCSPG matrix exhibited no change in invasion for both 
static and flow when compared to the control (Figure 18). All three matrices individually 
showed sensitivity to flow-induced invasion by a three to four fold increase in invasion 
when compared to the static control.  Hence, lower concentrations of bCSPG for both 
10kDa and 250kDa did not affect flow-induced invasion when compared to the control.  
Since the addition of lower concentration of both molecular weight bCSPG did not affect 
invasion, the permeability of the matrix at a higher concentration was tested. Our initial 
hypothesis suggested that an increased amount of biomimetic proteoglycans in the system 
would increase the osmotic pressure and thus decreasing the amount of flow going 
through the gel rapidly similar to a collagen-only gel. This was not observed in the 
permeability results shown in the previous section (Figures 6-8). Since this did not affect 
permeability, we tested the remaining media solution to understand whether the 
biomimetic proteoglycans were staying within the matrix or flowing through.  The high 
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concentration initially tested was 20 mg/ml of both bCSPGs and the controls that were 
being compared to were Matrigel and collagen-only gels.  
 
 
 
Figure 19: The high concentration of 20 mg/ml showed an effect on flow-induced invasion when 
bCSPG were present in the modified matrix. There was statistical significance between Matrigel and 
collagen + 250kDa bCSPG gels and a difference between both bCSPG gels (p<0.01).  
[The figure below invasion results is depicting the amount of bCSPG that has diffused out of the gel 
during the 24-hour invasion assay. These values were calculated by Dr. Katsiaryna Prudnikova. The 
bars depict combined static and flow conditions for each molecular weight bCSPG. The values are the 
percent leakage from gel. Therefore 80% of 250kDa bCSPG and 70% of 10kDa bCSPG leaked 
through the gel.] 
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Primarily, the collagen-only gel was used to determine differences in invasion when 
compared to all conditions in this study. The results showed a flow-induced invasion 
difference in the 250kDa bCSPG and Matrigel conditions (Figure 19). A greater amount 
of invasion was observed in both the static and flow conditions when comparing both 
matrices. Also, there was a difference between the 10kDa bCSPG and 250kDa bCSPG 
flow induced invasion (Figure 19). Both the 10kDa and Matrigel invasion results were 
similar to one another.  Qualitatively, most of the flow was going through the gel.  We 
wanted to ascertain whether the bCSPG molecules were staying within the matrix or 
leaving the gel. Flow through the remaining media below the transwell was tested. These 
results were collected by Dr. Katsiaryna Prudnikova, to determine the amount of leakage 
(personal communication with Dr. Prudnikova, 2013).  Most of the bCSPG molecules 
flowed out of the gel as seen in Figure 19 thereby not creating an osmotic pressure within 
the gels causing a greater amount of flow through the gels within the first half hour.  
Since these results showed that approximately 70% of the biomimetics leaked out of the 
gel, we proposed to use a much higher concentration in order to control the amount of 
bCSPG remaining within the gel. Hence, the next higher concentration tested was 
60mg/ml of the 250kDa bCSPG matrix. We hypothesized that there would be a similar 
invasion result to that of the 20mg/ml study and that more bCSPG would remain within 
the gel.  
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Figure 20: Little effect was eminent on flow-induced invasion when the concentration of bCSPG 
increased. However, there was a statistical significance in flow-induced invasion to the matrices 
individually (p<0.001). [The figure below invasion results shows the amount of leakage of 250kDa 
bCSPG through the gel was calculated by Dr. Katsiaryana Prudnikova. The values are the percent 
leakage from the gel.] 
 
 
 
The higher concentration study compared the 250kDa bCSPG gel to Matrigel and 
collagen-only gels to understand invasion differences. From the results, there was no 
invasion difference between all 3 conditions (Figure 20). However, there was an increase 
in invasion between the static and flow conditions individually for each matrix type. 
When comparing this result to the 20mg/ml study, an opposite effect occurred. This led to 
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understanding the amount of bCSPG that is leaking through the gel, which was found to 
be approximately 60-70% (Figure 20). Hence increasing the concentration of bCSPG 
within the gel did not change invasive characteristics of melanoma cells nor did it 
increase the amount of biomimetic molecules staying within the gel.  
Since each of these biomimetic molecules are made up of a polyacrylic acid core and 
chondroitin sulfate side chains, we tested these individual components, their effect on 
invasion, and the amount of material leaking out of the gel.  
We hypothesized that free chondroitin sulfate within the matrix would increase flow-
induced invasion of melanoma cells since growth-factor binding would occur between 
these two elements. The free chondroitin sulfate concentrations were chosen as a range 
from lowest concentration to highest concentration similar to the permeability study 
where 80% of 250kDa and 96% if the 10kDa is composed of chondroitin sulfate.  
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Figure 21:Free chondroitin sulfate affected invasion of melanoma cells at certain concentrations such 
as 15 mg/ml allowing for a decrease in invasion.  
[The figure below the invasion results depict the amount of free chondroitin sulfate leaving the gel 
and this data was produced by Dr. Katsiaryna Prudnikova. The values are the percent leakage from 
gel for each condition.] 
 
 
 
Results show that free chondroitin sulfate affects invasion of melanoma cells in certain 
concentrations, such as 15 mg/ml (Figure 21).  The free chondroitin sulfate concentration 
range similar to the bCSPG results are from 15-25mg/ml for the 20mg/ml invasion and 
permeability experiment. From this 20mg/ml invasion study we saw an effect on invasion 
as well. However, when comparing both results, the invasion was found to be lower with 
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a higher permeability in the free chondroitin sulfate experiment. Also, an interesting 
finding was that the flow-induced invasion was found to be inverse to the permeability of 
the matrix (Figure 9 and 21).  
The other individual component tested was PAA, as this is the core of the biomimetic 
proteoglycan molecule. We proposed that polyacrylic acid within the matrix would not 
significantly affect the invasion due to low concentrations being present in the bCSPG 
molecule. The polyacrylic aid concentrations were chosen as a range from lowest 
concentration to highest concentration similar to the permeability study where 20% of 
250kDa and 4% of the 10kDa is composed of this.  
 
 
 
 
Figure 22: As hypothesized, there was no effect on invasion when polyacrylic acid was incorporated 
within the matrix.  
 
 
 
Results showed that polyacrylic acid did not affect the invasion of melanoma cells 
thereby confirming the hypothesis (Figure 22). Also, the invasion to permeability 
difference showed that the invasion was much lower and the permeability was much 
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higher. The polyacrylic acid concentration range, 0.8-4mg/ml tested was similar to the 
bCSPG results for the 20mg/ml invasion and permeability study. Qualitatively, when 
running the assay, polyacrylic acid aggregated together in the gel matrix solution prior to 
gelation within the transwell. This could be due to polyacrylic acid having a reactive 
monomer, which is stabilized when attached to chondroitin sulfate (Sarkar and 
Marcolongo, 2010).  
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Chapter 4. DISCUSSION 
This thesis sought to identify the importance of extracellular matrix molecules within the 
tumor microenvironment and how they affect cancer progression at a cellular level. The 
focus was primarily on the characterization of an optimal in vitro tumor 
microenvironment and this environment’s affect on flow-induced invasion. 
Characterization of the in vitro environment was done by the removal of Matrigel and the 
addition of biomimetic proteoglycans that were synthesized in the Biomaterials 
laboratory at Drexel University (Dr. Michele Marcolongo). Matrigel is a basement 
membrane matrix that is primarily composed of various amounts of extracellular matrix 
proteins. This component is used in previous studies to mimic the basement membrane 
and is primarily composed of collagen type IV, laminin, heparin sulfate proteoglycans, 
and other growth factors [49].  The reason as to why Matrigel was removed out of our 
system is due to its poorly defined composition.  
It is known that proteoglycans are present in the ECM and the addition of these 
biomimetic proteoglycans, more specifically 250kDa biomimetic proteoglycan, would 
enable us to mimic a specific tumor microenvironment. Versican is a chondroitin sulfate 
proteoglycan that is found primarily in the skin have a molecular mass of greater than 
1000kDa and is observed to be in greater amount within a cancerous niche [39] . The 
250kDa biomimetic proteoglycan has a total molecular weight of 2010kDa therefore 
making them structurally similar to the biological proteoglycan of interest. Hence, the 
goal is to mimic a melanoma microenvironment by controlling the components that make 
up the matrix within an in vitro setting.  
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The characterization phase focused on the matrix permeability coefficients, as well as the 
cell and matrix morphology of the in vitro environment. Since this study was mimicking 
the in vivo tumor microenvironment, invasion studies were done to determine the effect 
of these matrix molecules on melanoma cells. We were able to observe the differences 
between varied matrix conditions. More importantly, during the characterization of the 
matrix, the differences seen were in physical properties of the gel, more specifically in 
the collagen fiber morphology. When looking at the invasive characteristics of melanoma 
cells in this environment, there was a change in invasion in the matrices that had higher 
concentrations of bCSPG.  
Biomimetic chondroitin sulfate proteoglycans significantly altered the collagen matrix structure 
and affected the permeability of these varied matrices 
 
One of the major goals of this study was to validate the use of biomimetic proteoglycans 
for in vitro models of the tumor microenvironment.  Critical to this validation was 
determining how the biomimetic proteoglycans altered the matrix microenvironment 
experienced by the cells.  The removal of Matrigel and addition of biomimetic 
proteoglycans of molecular weights, 10kDa and 250kDa resulted in various changes to 
the matrix. The reason to using two different molecular weight biomimetics, was to 
understand how the different degrees of decoration to both proteoglycans can change the 
components being studied. Cells experience different fluid flow velocities within 
different environments, and since we are modifying our environment matrix permeability 
is being studied to understand these changes. Firstly, the permeability of the matrix 
changed when bCSPGs were added when compared to the Matrigel and collagen-only 
matrices. This was an expected result as Matrigel is composed of multiple extracellular 
proteins and growth factors, which could therein affect permeability. However, we 
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proposed that by using these biomimetic proteoglycans similar in structure to versican, 
we would be able to elevate osmotic pressure in the matrix, allowing for a decrease in 
permeability. It is proposed that these molecules have the ability to pull in water (Sarkar 
and Marcolongo, 2010) thereby creating this pressure. Results for the lower concentration 
of bCSPG showed a slight difference in permeability between collagen-only gel and 
bCSPG gels. The opposite effect to the hypothesis occurred, having an increased 
permeability in the bCSPG gels. A reason to this increased permeability could be due to 
insufficient generation of osmotic pressure. This variance between matrices is a positive 
result since we were expecting a change in permeability. One component within Matrigel 
that is not in the modified matrix, collagen type IV, would affect the permeability change. 
Collagen type IV is different in structure to collagen type I, where it is more fibrillar and 
mesh-like. It is known that Matrigel shows resistance to flow through the collagen fiber 
matrix. A possible addition of collagen type IV which created more of a mesh may help 
in flow traffic through the matrix [50]. Since a slight dissimilarity was seen between the 
all three varied matrices, hence we explored the path of using higher concentrations of 
bCSPG. Another reason of using higher concentrations was the resulting leakage of 
bCSPG’s through the gels. From the high concentration study, we were able to find 
distinct disparity of the permeability between the collagen-only and collagen+ bCSPG. 
We were expecting a permeability change in these matrices as there was a greater amount 
of bCSPG staying within the gel thereby affecting the hydrostatic pressure. However, the 
disparity lead to an increase in permeability for bCSPG matrices when compared to 
Matrigel and this was still due to the leakage of bCSPGs through the gel hence having no 
generation of osmotic pressure. More specifically, it is known that the highly negative 
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charges of chondroitin sulfate chains produce an osmotic pressure in a form of a 
“hydrated state” can play a role in compressive mechanical stress [51].  This osmotic 
pressure was not forming since the biomimetics were not able to stay within the gel. This 
was evident since the structure of the matrix containing biomimetics was not uniform and 
created void spaces allowing for this to occur. We hypothesized that this change in 
permeability would affect the invasion of melanoma cells through this matrix by altering 
the flow velocity (since the hydrostatic pressure head in the flow invasion assay would 
stay the same).  This could potentially confound results, since changes in invasion could 
be due to changes in interstitial flow or due to cell-bCSPG interactions.  However, these 
findings suggest that bCSPGs over a wide range of concentrations had minimal effects on 
matrix permeability, especially compared to a typical matrix formulation containing 1 
mg/ml Matrigel.  
Physical property variance was eminent between matrix types. A qualitative 
measurement of gel formation above the membrane of the transwell was recorded for 
each in vitro environment. The conditions with Matrigel and collagen-only formed a gel, 
however the conditions with bCSPG formed a thin film. Another observation was seen in 
that the matrices that included both molecular weight biomimetic proteoglycans remained 
a viscous liquid rather than forming a gel similar to invasion studies. We believed a gel 
was not forming due to the variance in pH between the matrices. It is understood that the 
biomimetic proteoglycans are anionic molecules therefore having a negative charge and 
affecting pH. When tested, the pH of the collagen-only and both bCSPG gels had pH of 
6. Although charges may have an effect on the pH, varying pH of the chondroitin sulfate 
proteoglycan does not change the hydraulic permeability of the matrix [52, 53]. 
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Since there was a disparity in physical properties between the varied compositions of 
matrices, we wanted to determine whether these differences were prominent in the 
structure of the matrices. In order to pursue this goal, cell morphology and fiber 
morphology studies were done to determine structural and cellular architecture variance. 
Since physical property variance was evident in the conditions with bCSPG, an initial 
obstacle that occurred in imaging was during the staining and fixing. However, results 
showed a dense and evenly distributed amount of collagen fibers throughout the collagen-
only matrix while the 10kDa matrix showed cell-cell interaction and thicker collagen 
fibers. This cell-cell interaction in the 10kDa matrix could be due to the voids of collagen 
fibers. Since there was a change in fiber morphology, we wanted to delve further to 
understand whether this result was evident in an acellular matrix. We expected changes in 
structural fibril morphology since the glycosaminoglycan side chains would interact with 
the collagen fibers thereby creating a bridge. This study showed the most significant 
results with regards to structural variance between the three different in vitro 
environments.  The collagen-only matrix showed a dense and uniformly distributed 
amount of fibers throughout the matrix. Both the 10kDa and 250kDa gels showed uneven 
distribution with void space and clustered fibrils. Clustered fibril results were similar to 
Yang et al which looked at mechanical and structural properties of collagen type I gels 
with chondroitin sulfate and hyaluronic acid. They retained similar results suggesting that 
chondroitin sulfate can induce these fibers form bundling together and forming clusters 
[54]. Also, the uneven distribution of clustering through the bCSPG matrices showed 
void spaces present. This result was also seen in an in vitro  experiment done by Stuart et 
al, exemplifying the spaces in between the collagen fibers [55]. Also, the evidence of 
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cells not sitting on the collagen clusters but sitting within the spaces suggests that these 
cells could be interacting with the biomimetic proteoglycans since they are held in that 
position. Altogether, the most significant results resembled the fibrillar changes between 
the three different in vitro environments tested. These findings suggest a slight negative 
result due to significant changes in collagen structure and network in the presence of 
bCSPGs. Hence this implies, that we would need to modify the system to create a more 
uniform collagen network through the addition of other components that are found in the 
tumor specific matrix. 
The modified biomimetic proteoglycan and collagen matrix affected flow-induced invasion of 
melanoma cells, MDA-MB-435s at higher concentrations  
 
The objective was to understand how an altered matrix could affect melanoma cell 
invasion through the addition of biomimetic proteoglycans. The cancer cell line, MDA-
MB-435s cells is known to be of melanoma origin, and was the primary cell line of use 
throughout the invasion study [44-46].  The goal was to create varied in vitro tumor 
microenvironments with a similar physiological interstitial flow property. An initial 
control study and previous studies have shown the melanoma cell line to be sensitive to 
flow-induced invasion [14, 48].  
 The different microenvironments consisted of Matrigel (contained both Matrigel and 
collagen), collagen-only, and collagen + bCSPG of both molecular weights. We 
hypothesized that these cells would interact with the chondroitin sulfate side chains 
causing growth factor binding thereby leading to invasion through the matrix.  
The addition of lower concentrations of biomimetic proteoglycans showed little to no 
effective change on invasive characteristics of melanoma cells. This was due to the 
leakage of bCSPG through the gel, hence little interaction between the melanoma cells 
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and chondroitin sulfate bristles occurred. However, each individual conditioned matrix, 
showed sensitivity to flow-induced invasion having a significant increase from static to 
flow conditions in all three microenvironments. This was a positive results that was also 
seen in the studies signifying this cell line’s sensitivity to flow-induced invasion [14, 48].  
The use of higher concentrations bolstered the fact that physiologically, there is an 
increase in expression of proteoglycans within a cancerous niche [37]. Therefore, the goal 
was to have a higher concentration in order to closely mimic the in vivo environment. 
While mimicking the environment, we wanted to imitate similar flow environment as 
well. Hence the flow conditions were set so that the interstitial flow velocity values 
would be in the physiological range of 0.1-1.0 µm/s [21].  
The addition of higher concentrations for both molecular weight biomimetic 
proteoglycans showed a positive flow-induced invasion effect. This effect was 
prominently seen in the difference between the Matrigel and 250kDa bCSPG 
environments. Also, a difference in flow-induced invasion was prominent between both 
bCSPG matrices. We hypothesized that this result occurred due to the variation in size 
and degrees of decoration of the chondroitin sulfate side chains. The 10kDa bCSPG is 
much smaller molecule than the 250kDa bCSPG hence these molecules could easily fit 
between the spaces of the collagen fiber matrix. This would allow for the interaction 
between the chondroitin sulfate side chains and the melanoma cells allowing for 
decreased invasion as seen in the results (Figure 19). Another reasoning to these 
differences in invasion can be due to the difference in fluid flow properties through the 
varied in vitro environments rather than the matrix composition. We further proposed to 
increase the concentration of 250kDa bCSPG since leakage of the biomimetic was 
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occurring. In the 60mg/ml study, results showed a similar effect where there was an 
increased invasion in the gels containing 250kDa biomimetic proteoglycan when 
compared to the collagen-only (Figure 20). Although there was a high leakage of bCSPG 
through the gel during the invasion assay, we expected some biomimetic proteoglycans to 
still remain within the gel causing this invasion. The highest physiological concentration 
of proteoglycans in tissue would be 80mg/ml, hence we remained within the 
physiological range even at this high of a concentration[51].  
These studies resulted an evident increase in flow-induced invasion, more specifically in 
the gels containing Matrigel and biomimetic proteoglycans. Therefore, our hypothesis of 
growth factor binding was evident in the matrices containing biomimetic proteoglycans. 
Melanoma cells were able to express the chemokine CCL21 in order to bind to the 
sulfated glycosaminoglycan side chain of the chondroitin sulfate bristle and create a 
gradient leading to chemotaxis and migration through the matrix [21, 56]. It is known that 
stromal glycosaminoglycans and proteoglycans tend to compete for chemokine receptor 
binding[57] . Versican tends to interact with chemokine receptor CCR7 within the tumor 
microenvironment through its glycosaminoglycan side chains[58] rather than the protein 
core. Hence this bolsters our hypothesis that the 250kDa biomimetic proteoglycan 
influenced flow-induced invasion through chemokine interaction between the side chains.  
Other studies using biological larger chondroitin sulfate proteoglycans such as versican 
showed similar results. Results showed an increased invasion when versican was present 
in the matrix. The biomimetic 250kDa proteoglycan is of similar structure to versican and 
this bolstered the functional effect as well. Therefore, although the core is biologically 
inert the chondroitin sulfate side chains have a profound effect on invasion of cancer cells 
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[36, 39]. At a clinical standpoint, the presence of versican within the matrix worsens 
prognosis for malignant melanoma[59].  
Conclusively, a change in the structural properties of the matrix did affect the invasion 
characteristics as well.  The  bCSPG-melanoma interactions were evident in the spaces 
between the collagen fibril clusters within the matrix. Hence 250kDa biomimetic 
proteoglycan was able to influence flow-induced invasion of melanoma cells at higher 
concentrations.  
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Chapter 5. SIGNIFICANCE AND FUTURE DIRECTIONS 
An important factor for understanding cancer involves specifically looking at a local 
microenvironment that develops from a normal tissue to a cancerous niche. There is still 
a vague conception of the transition between these two states. However it is know that the 
extracellular matrix plays an important role in this transition through remodeling [29]. 
This study sought to address how changes in proteoglycan content and structure can 
affect the properties of the matrix and interstitial flow-induced invasion of cancer cells. 
One of the key goals of this study to replace Matrigel with biomimetic proteoglycans to 
create a more defined in vitro system. To this end, bCSPG-collagen gels were 
characterized and used in invasion assays to determine the functional purpose of these 
extracellular matrix molecules in cancer biology. Characterization of the matrix was 
accomplished through understanding the variances in matrix permeability. A significant 
result determined was that matrices containing biomimetic proteoglycan differed in 
collagen fibrillar structure than the control collagen-only matrix. Therefore, this bolstered 
the fact that addition of proteoglycans was changing the structure. But the question 
arised, of whether this change in structure affected the invasion through the matrix. The 
invasive properties of a melanoma cell line, MDA-MB-435s, were determined through a 
three-dimensional in vitro transwell invasion assay. A significant result was found in the 
higher concentration showing an increase in flow-induced invasion between the 250kDa 
biomimetic matrix and the control matrices and the difference between the two different 
molecular weight matrices. Also, each individual matrix evidently showed an increase in 
flow-induced invasion as well. The result of higher invasion in the 250kDa matrix was 
similar to previous studies indicating that chondroitin sulfate proteoglycans increase 
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invasion and migration of cancer cells through a chemokine gradient [21, 56]. This result 
was the most accomplished for this study leading to future directions in this research. The 
major impact to this work was the ability to understand these changes in matrix in the 
presence of biomimetic proteoglycans and their effect on flow-induced invasion.  
The future in this research is to further characterize the system and understand how 
changes in the matrix can affect invasion of various types of cancer cells. Another 
important aspect for this research is to study the interactions between chemokines and the 
GAG side chains of the bCSPGs. One forthcoming goal of characterizing the system is to 
create a more controlled in vitro environment by specifically adding the components that 
are present in a certain tumor type. This characterization would enable us to specifically 
analyze the molecular components to how a matrix is affected in cancer. Since Matrigel 
contained heparan sulfate proteoglycans that are important components of the basement 
membrane, future systems could incorporate biomimetic heparan sulfate proteoglycans. 
These molecules would be created in a similar fashion as the biomimetic chondroitin 
sulfate proteoglycans however; the side chains would be heparan sulfate. Also, further 
characterization of ensuring the correct amount of biomimetic proteoglycans present 
within the matrix would need to be done. In part, this would involve addressing the loss 
of bCSPGs observed in our gels. A solution would be to add a higher concentration in 
order to account for the loss and the addition of mesh-like collagen type IV. The possible 
addition of mesh-like collagen type IV would enable a denser matrix thereby holding the 
biomimetic proteoglycans in place and allowing for better flow trafficking leading to a 
decrease in permeability, which is the desired outcome. Once heparan sulfate 
biomimetics and collagen type IV, would be added to the system, collagen fibril and cell 
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morphology studies should be done to ensure for structural integrity.  If the structure of 
this matrix results in a similar manner to the results shown in this thesis, it would be 
worth trying to image the glycosaminoglycan side chains through Hale staining to 
understand their presence within the in vitro matrix [60]. Since the modeling of the 
matrix would affect the invasion of cancer cells, an invasive study should be done using 
varied cancer cell types. In order to study a particular cancer, the in vitro system would 
be tailored to that cancer cell type to further study the migration properties of these cells 
and the invasion through this specific matrix. These would by analyzed through similar 
methods to this proposal. The primary goal of studying invasion is to determine whether 
growth-factor binding between proteoglycans and cancer cells can induce a chemokine 
gradient leading to invasion through the matrix.  
 
This thesis’s primary goal was to understand the effects of biomimetic proteoglycans on 
matrix characteristics such as permeability and structural morphology as well as the 
invasion through this matrix. Characterization of the in vitro system through the addition 
of biomimetic proteoglycans enabled us to control matrix properties. The permeability 
between matrix types varied structurally seen through collagen fiber variance. Also, 
matrix permeability was slightly affected through addition of biomimetic proteoglycans 
within the matrix. Invasion exhibited positive results showing flow-induced invasion of 
each matrix individually, between control and the 250kDa biomimetic matrix, and 
between both molecular weight matrices. This was of similar results to previous studies 
since the 250kDa biomimetic was of similar structure to the biological proteoglycan of 
interest versican. This study contributed to understanding invasion at a cellular level 
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through the effect of biomimetic molecules within a biological system. An impact to this 
study, is the first time potential use of these molecules to mimic natural proteoglycans.  
The understanding of how biomimetic proteoglycans can affect the matrix structurally 
was a confounding result to this study. Future research of understanding the interaction 
between the glycosaminoglycan side chains of these biomimetics and cancer cells will 
further bolster the analysis of chemotaxis. Biomimetic proteoglycans are novel elements 
that can be used to understand a cancerous microenvironment through a controlled 
manner. They are a beneficial tool to construct an in vitro extracellular matrix and study 
its effects on migration.  In conclusion, the addition of 250kDa biomimetic proteoglycans 
did affect the matrix properties as well as create a chemokine gradient thereby having 
flow-induced invasion. This is the beginning to mimicking an in vitro tumor 
microenvironment through novel biomimetic tools to further understand cancer biology. 
Moving forward, the use of biomimetic molecules to mimic the tumor microenvironment 
can help determine their influence on cellular behavior, matrix remodeling, and disease 
progression. 
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